{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:04:55Z","timestamp":1759665895396},"reference-count":26,"publisher":"AACN Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:p>A patient with severe toxic epidermal necrolysis underwent 2 cycles of therapeutic plasma exchange and received specialized wound care for widespread skin damage of more than 80% of his body surface area. Extensive involvement of mucous membranes, including the conjunctivas and the oropharyngeal cavity, and damage of his genitourinary organs required meticulous wound care. Daily care of injuries of tissues affected only in the most severe cases of toxic epidermal necrolysis was provided by an experienced intensive care unit nursing team. A meticulous supportive therapy regimen was a major contributing factor to this patient\u2019s remission.<\/jats:p>","DOI":"10.4037\/ccn2013555","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T07:24:58Z","timestamp":1375341898000},"page":"26-38","source":"Crossref","is-referenced-by-count":13,"title":["Supportive Therapy for a Patient With Toxic Epidermal Necrolysis Undergoing Plasmapheresis"],"prefix":"10.4037","volume":"33","author":[{"given":"Bozena","family":"Seczynska","sequence":"first","affiliation":[{"name":"All authors are affiliated with Jagiellonian University Medical College, Krakow, Poland. Bozena Seczynska is an intensive care nurse in the Department of Medicine."},{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Nowak","sequence":"additional","affiliation":[{"name":"Ilona Nowak is an intensive care nurse in the Department of Medicine."},{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia","family":"Sega","sequence":"additional","affiliation":[{"name":"Aurelia Sega is an intensive care nurse in the Department of Medicine."},{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kozka","sequence":"additional","affiliation":[{"name":"Maria Kozka is an assistant professor in nursing, Department of Clinical Nursing, Institute of Nursing and Midwifery, Faculty of Health Sciences. She is a lecturer at the Institute of Nursing."},{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wodkowski","sequence":"additional","affiliation":[{"name":"Michael Wodkowski is an intern in intensive care in the Department of Medicine."},{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wieslaw","family":"Kr\u00d3likowski","sequence":"additional","affiliation":[{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Szczeklik","sequence":"additional","affiliation":[{"name":"Wieslaw Kr\u00f3likowski is the director of the intensive care unit in the Department of Medicine."},{"name":"Wojciech Szczeklik is an attending physician in the intensive care unit, Department of Medicine."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","reference":[{"key":"2019112601212953600_b1-0330026","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2019112601212953600_b2-0330026","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","article-title":"Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre","volume":"35","author":"Rajaratnam","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"2019112601212953600_b3-0330026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"issue":"4","key":"2019112601212953600_b4-0330026","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ACI.0b013e328355b865","article-title":"Immunological mechanisms of epidermal damage in toxic epidermal necrolysis","volume":"12","author":"Tohyama","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"2019112601212953600_b5-0330026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2019112601212953600_b6-0330026","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"2019112601212953600_b7-0330026","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2019112601212953600_b8-0330026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1744-9987.2008.00609.x","article-title":"Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan","volume":"12","author":"Yamada","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"6","key":"2019112601212953600_b9-0330026","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00128071-200607060-00004","article-title":"Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"7","author":"Mittmann","year":"2006","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"2019112601212953600_b10-0330026","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas","year":"2002","journal-title":"Ther Apher"},{"issue":"3","key":"2019112601212953600_b11-0330026","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1744-9987.2009.00800.x","article-title":"Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis","volume":"14","author":"Szczeklik","year":"2010","journal-title":"Ther Apher Dial"},{"issue":"4","key":"2019112601212953600_b12-0330026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jca.21213","article-title":"Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases","volume":"27","author":"Ko\u0161t\u00e1l","year":"2012","journal-title":"J Clin Apher"},{"issue":"3","key":"2019112601212953600_b13-0330026","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1346-8138.2010.01154.x","article-title":"Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: is cytokine expression analysis useful in predicting its therapeutic efficacy?","volume":"38","author":"Narita","year":"2011","journal-title":"J Dermatol"},{"issue":"4","key":"2019112601212953600_b14-0330026","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"2019112601212953600_b15-0330026","doi-asserted-by":"publisher","DOI":"10.1186\/cc6141","article-title":"Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database","volume":"12","author":"George","year":"2008","journal-title":"Crit Care"},{"issue":"2","key":"2019112601212953600_b16-0330026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","volume":"126","author":"Gu\u00e9gan","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2019112601212953600_b17-0330026","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2019112601212953600_b18-0330026","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.PRS.0000019761.69444.10","article-title":"Outcome of patients with toxic epidermal necrolysis syndrome revisited","volume":"110","author":"Ducic","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"2019112601212953600_b19-0330026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019112601212953600_b20-0330026","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients","volume":"34","author":"Boorboor","year":"2008","journal-title":"Burns"},{"issue":"1","key":"2019112601212953600_b21-0330026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med"},{"issue":"4","key":"2019112601212953600_b22-0330026","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1478-5153.2007.00225.x","article-title":"Blood glucose control in critical care patients\u2014a review of the literature","volume":"12","author":"Parsons","year":"2007","journal-title":"Nurs Crit Care"},{"issue":"5","key":"2019112601212953600_b23-0330026","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/WON.0b013e3181b414ed","article-title":"Topical treatment protocol for Stevens-Johnson syndrome and toxic epidermal necrolysis: a brief report","volume":"36","author":"Evans","year":"2009","journal-title":"Wound Ostomy Continence Nurs"},{"issue":"10","key":"2019112601212953600_b24-0330026","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","article-title":"Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"46","author":"Fromowitz","year":"2007","journal-title":"Int J Dermatol"},{"issue":"2","key":"2019112601212953600_b25-0330026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1529-8019.2011.01396.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options","volume":"24","author":"Worswick","year":"2011","journal-title":"Dermatol Ther"},{"issue":"9","key":"2019112601212953600_b26-0330026","first-page":"637","article-title":"Plasmapheresis\u2014possible complications and their prevention","volume":"68","author":"Seczynska","year":"2011","journal-title":"Przegl Lek"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/33\/4\/26\/117240\/26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/33\/4\/26\/117240\/26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T06:22:01Z","timestamp":1574749321000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/33\/4\/26\/3369\/Supportive-Therapy-for-a-Patient-With-Toxic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2013555","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}